Lumbar disc herniation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Enter the group voluntarily, agree and sign the informed consent; 2) more than two of the diagnostic criteria 1.1 or 1.2 and 1.3 for lumbar disc herniation; 3) Aged between 20 and 65; 4) No other treatment or medication has been used in the past 2 weeks. 5) Patients have treatment requirements and can adhere to the treatment as planned, and can cooperate with clinical observers and follow-up. 6) Subjects can understand and sign informed consent after fully understanding the nature of this study, the nature of their disease, the characteristics of the drugs under test, the relevant treatment methods and the risks that may be borne by participating in this study.
Exclusion criteria
Exclusion criteria: 1) Does not meet the inclusion criteria; 2) Other related bone and joint diseases, including lumbar instability, lumbar spinal stenosis, lumbar tuberculosis, spinal cord tumor, etc.; 3) patients with serious primary diseases of hematopoietic system, cardiovascular system and endocrine system, tumors and mental disorders; 4) women in pregnancy and lactation; 5) Currently participating in other drug or clinical research related to the disease; 6) Mentally, mentally or mentally abnormal and unable to cooperate with treatment.